U.K. Coronor Says AstraZeneca’s Covid Vaccine Caused ‘Fit and Healthy’ Young Man to Die from Blood Clot in Brain

A 27-year-old man in England developed a blood clot in the brain and died on Apr. 20, 2021, three weeks after receiving the first dose of AstraZeneca/Oxford University’s experimental viral vectored Covid-19 vaccine Vaxzevria (also known as AZD1222), and a U.K. coroner determined his death was causally related to the vaccination. Jack Last of Stowmarket in Suffolk, England was vaccinated on Mar. 30, 2021 and a week later developed a “throbbing headache,” suffered spells of vomiting and was admitted to a local hospital. A CT scan of his brain taken on Apr. 10 showed a cerebral sinus thrombosis (CVST) and Last passed away 10 days later.^{1 2 3 4}

According to Johns Hopkins Medicine:

Cerebral venous sinus thrombosis (CVST) occurs when a blood clot forms in the brain’s venous sinuses. This prevents blood from draining out of the brain. As a result, blood cells may break and leak blood into the brain tissues, forming a hemorrhage.⁵

Coroner Attributes Last’s Death to Vaxzevria

There was a year long investigation into Last’s death by United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).  After a subsequent court inquest, senior coroner Nigel Parsely stated in Suffolk Coroner’s Court last month that he concluded the vaccine triggered an “over-reactive immune response,” which caused blood clots in several areas of Last’s body.² Parsely said:

Jack Last died of a blood clot to the brain, caused as a direct result of his body’s reaction to the AstraZeneca Covid-19 vaccination which he had received on March 30, 2021.¹

Last, an engineer and amateur pilot, was described by members of his family as ‘fit and healthy’ and ‘fit as ever” before he got the Vaxzeria vaccine. His sister said, “It was very unusual for Jack to feel unwell at all. To my knowledge, he had never had a day off work due to illness.” He was an “adventurer,” she said. “He managed to fit in so much including canoeing, canyoning, going in a shark cage, bungee jumping, the world’s longest zip wire, and saw AC/DC live.”^{1 2 3 4}

Dr. William Petchey, a nephrologist at West Suffolk and hospitals in Cambridge, England, told the inquest that at first, he had ruled out any link between the Vaxzevria and the Last’s blood clot. “It’s hard to explain now what this was like. This was not a condition any of us had trained for, or which we had experience with,” Dr. Petchey said.⁶

Dr. Martin Besser, a haematologist at Cambridge University hospitals, stated during the inquest that, at the time of Last’s death, there was uncertainty about a possible relationship between Vaxzevria and blood clots.⁶

European Countries Limit or Suspend Use of Vaxzevria

Just weeks after Last’s death, a study published in the British medical journal The BMJ on May 5, 2021 found increased rates of blood clots in veins, or “venous thromboembolism,” in people who received a first dose of Vaxzevria compared to blood clot rates in the broader population. The MHRA recommended that people under 40 years old be administered other Covid vaccines, rather than Vaxzevria, whenever possible. The European Medicines Agency (EMA) also acknowledged that there is a risk of blood clotting linked to Vaxzevria. This influenced decisions by public health officials in a number of European countries to limit the vaccine to individuals 60 years of age and older.^{7 8}

On Mar. 11, 2021, Denmark became the first country to permanently ban the use of Vaxzevria over fears of blood clotting. Other European countries, including Austria, Estonia, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Norway and Sweden, shortly followed and suspended use of the vaccine as well.^{8 9}

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.